Educational Interventions for Genetic Testing in Black Men with Prostate Cancer

This study is looking at how an educational video can help Black men with high-risk prostate cancer understand and complete genetic testing. The goal is to improve the number of Black men who get this important testing, which is recommended by cancer guidelines. You could be eligible if you are a Black man, 18 or older, diagnosed with prostate cancer, and meet specific guidelines for genetic testing. The study will measure how many people complete genetic testing over 24 months. The current status of the study is unclear.

Study design
This is a single-arm study, meaning all 50 participants will receive the educational intervention. It is a quality improvement initiative.
What's involved
You would participate in a one-on-one educational session with a trained staff member. You would also complete short questionnaires before and after the session.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome of genetic testing rates will be measured at 24 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05958082

Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer

Recruiting
NAAges 18+InterventionalHealth services
Henry Ford Health System
~50 participants
Updated 2026-07-15 on ClinicalTrials.gov
What's tested:Educational video

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Testing rate
Measured over 24 months
Prostate Cancer
1 sites across 1 states
Michigan1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

a first degree relative with prostate cancer or more than one first/second degree relative with prostate cancer, or
≥3 cancers on same side of family, especially diagnoses ≤50 years of age: bile duct, breast, colorectal, endometrial, gastric, kidney, melanoma, ovarian, pancreatic, prostate (but not clinically localized Grade Group 1), small bowel, or urothelial cancer 2. Men with high-risk, very-high risk (per NCCN definitions of risk groups), lymph node positive, or metastatic prostate cancer independent of family history of histology.
  • Testing rate24 months

    percentage of patients who undergo genetic testing after completing the education session